Canine Vaccine

Verify with FDA CVM →

389 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
389
Total Reports
31
Deaths Reported
800.0%
Death Rate

Active Ingredients

Canine Vaccine

Administration Routes

UnknownSubcutaneousNasal

Species Affected

Dog 389

Most Affected Breeds

Retriever - Labrador 40
Terrier - Bull - American Pit 25
Chihuahua 20
Terrier - Yorkshire 16
Boxer (German Boxer) 13
Siberian Husky 12
Retriever - Golden 12
Shepherd Dog - Australian 11
Maltese 11
Crossbred Canine/dog 10

Most Reported Reactions

Vomiting 147
Facial swelling (see also 'Skin') 92
Lethargy (see also Central nervous system depression in 'Neurological') 91
Anaphylaxis 61
Hives (see also 'Skin') 60
Diarrhoea 36
Pale mucous membrane 36
Fever 30
Seizure NOS 23
Collapse NOS (see also 'Cardio-vascular' and 'Neurological disorders') 22
Erythema (for urticaria see Immune SOC) 20
Pruritus 20

Outcome Breakdown

Ongoing
191 (49.1%)
Recovered/Normal
151 (38.8%)
Died
17 (4.4%)
Outcome Unknown
16 (4.1%)
Euthanized
14 (3.6%)

Data Summary

Metric Value
Total adverse event reports 389
Reports involving death 31
Case-fatality rate (reported events) 800.0%
Distinct species in reports 1
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Canine Vaccine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 389 adverse event reports referencing Canine Vaccine, including 31 reports in which the animal died — a 800.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Canine Vaccine. Reported administration routes include Unknown, Subcutaneous, Nasal. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Canine Vaccine reports are Dog (389 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (40), Terrier - Bull - American Pit (25), Chihuahua (20) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Canine Vaccine are Vomiting (147), Facial swelling (see also 'Skin') (92), Lethargy (see also Central nervous system depression in 'Neurological') (91), Anaphylaxis (61). Of the 389 reports with a coded outcome, Ongoing is the leading category at 49.1%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Canine Vaccine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial